QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
ImmunityBio, Inc.
University of Washington
Novartis
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Bristol-Myers Squibb
GU Research Network, LLC
University of California, San Francisco
Hoffmann-La Roche
Incyte Corporation
Incyte Corporation
The Netherlands Cancer Institute
Yonsei University
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Washington University School of Medicine
Vanderbilt-Ingram Cancer Center
Cancer Trials Ireland
Louisiana State University Health Sciences Center Shreveport
Pfizer
University of Southern California
University of Southern California
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Aktion Bronchialkarzinom e.V.
National Cancer Institute (NCI)
Spectrum Pharmaceuticals, Inc
Massachusetts General Hospital
Barbara Ann Karmanos Cancer Institute
University College, London